Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Bokslutskommuniké for Cline Scientific AB (publ), 556867-8238, for the period 1 January - 31 December 2023

Cline Scientific
Download the release

Cline Scientific AB (publ) ("Cline" or the "Company") issues the following bokslutskommuniké for 2023.

July - December 2023 
  • Net sales amounted to SEK 0 (0).
  •  Operating profit amounted to SEK 240,145 (237,140).
  • Profit per average number of shares after tax amounted to 0.01 (0.01)
January - December 2023
  • Net sales amounted to SEK 0 (0).
  •  Operating profit amounted to SEK -3,108,861 (-2,317,061)
  • Profit per average number of shares after tax amounted to -0.10 (-0.15)

The report is published at www.clinescientific.com/financial-reports

For more information, please contact:
Patrik Sundh, CEO
Email: patrik.sundh@clinescientific.com
Phone: +46 703-585 088

The company is listed on the Nasdaq First North Growth Market. Redeye AB is Cline Scientific's Certified Adviser. The information was submitted for publication via the contact person listed above, at 8.30am CET on 23 February 2024.

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.